drugset / Trial / NCT01061697

Pregabalin and Radicular Pain Study (PARPS)

NCT01061697

Phase 4 Completed 50 enrolled Singapore General Hospital Pfizer · collab
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to investigate the effectiveness of pregabalin (Lyrica) on nerve pain caused by degenerative neck problems. Pregabalin is a new drug registered for use in nerve pain worldwide

Timeline

Start
2008-01
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg
Subject Pregabalin Small molecule 150 mg